Your browser doesn't support javascript.
loading
What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward.
Kc, Sarin; Lin, Lydia Wenxin; Bayani, Diana Beatriz Samson; Zemlyanska, Yaroslava; Adler, Amanda; Ahn, Jeonghoon; Chan, Kelvin; Choiphel, Dechen; Genuino-Marfori, Anne Julienne; Kearney, Brendon; Liu, Yuehua; Nakamura, Ryota; Pearce, Fiona; Prinja, Shankar; Pwu, Raoh-Fang; Akmal Shafie, Arsul; Sui, Binyan; Suwantika, Auliya; Tunis, Sean; Wu, Hui-Min; Zalcberg, John; Zhao, Kun; Isaranuwatchai, Wanrudee; Teerawattananon, Yot; Wee, Hwee-Lin.
Afiliación
  • Kc S; Health Intervention and Technology Assessment Program (HITAP), Ministry of Health, Nonthaburi, Thailand.
  • Lin LW; Saw Swee Hock School of Public Health, National University of Singapore (NUS), Singapore, Singapore.
  • Bayani DBS; Saw Swee Hock School of Public Health, National University of Singapore (NUS), Singapore, Singapore.
  • Zemlyanska Y; Saw Swee Hock School of Public Health, National University of Singapore (NUS), Singapore, Singapore.
  • Adler A; The Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, UK.
  • Ahn J; Ewha Womans University, Seoul, South Korea.
  • Chan K; Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.
  • Choiphel D; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Genuino-Marfori AJ; Canadian Centre for Applied Research in Cancer Control, Toronto, ON, Canada.
  • Kearney B; Essential Medicine and Technology Division, Department of Medical Services, Ministry of Health, Thimphu, Bhutan.
  • Liu Y; Health Technology Assessment Unit, Department of Health, Quezon City, Philippines.
  • Nakamura R; Faculty of Medicine, University of Adelaide, Adelaide, SA, Australia.
  • Pearce F; Health Policy Advisory Committee on Technology, Brisbane, QLD, Australia.
  • Prinja S; China Health Technology Assessment Centre, National Health Development Research Centre, Ministry of Health, Beijing, China.
  • Pwu RF; Hitotsubashi Institute for Advanced Study, Hitotsubashi University, Tokyo, Japan.
  • Akmal Shafie A; Agency for Care Effectiveness, Ministry of Health, Singapore, Singapore.
  • Sui B; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Suwantika A; Taiwan National Hepatitis C Program Office, Ministry of Health and Welfare, Taipei, Taiwan.
  • Tunis S; Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
  • Wu HM; China Health Technology Assessment Centre, National Health Development Research Centre, Ministry of Health, Beijing, China.
  • Zalcberg J; Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
  • Zhao K; Center for Medical Technology Policy (CMTP), Baltimore, MD, USA.
  • Isaranuwatchai W; Taiwan National Hepatitis C Program Office, Ministry of Health and Welfare, Taipei, Taiwan.
  • Teerawattananon Y; Cancer Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Wee HL; Department of Medical Oncology, Alfred Hospital, Melbourne, VIC, Australia.
Int J Health Policy Manag ; 12: 6858, 2023.
Article en En | MEDLINE | ID: mdl-37579427
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Formulación de Políticas / Evaluación de la Tecnología Biomédica Tipo de estudio: Guideline / Health_technology_assessment / Prognostic_studies / Qualitative_research Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Int J Health Policy Manag Año: 2023 Tipo del documento: Article País de afiliación: Tailandia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Formulación de Políticas / Evaluación de la Tecnología Biomédica Tipo de estudio: Guideline / Health_technology_assessment / Prognostic_studies / Qualitative_research Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Int J Health Policy Manag Año: 2023 Tipo del documento: Article País de afiliación: Tailandia